“a decreasing trend”

After the policy change, there was a decreasing trend, consistent with the reduction observed in virtual care, with a slope change of –61.8 (95% CI –78.6 to –45; P <.001), corresponding to 25.9 fewer in-person visits per week in period 2 compared to those in period 1 and an overall reduction of 32.1 total visits per week between the two periods.

Although both the intervention and control groups showed a decreasing trend in sleep latency at posttest (intervention: adjusted mean difference −27.80 minutes/day, 95% CI −33.07 to −22.53, P <.001; control: −26.05 minutes/day, 95% CI −31.22 to −20.89, P <.001) and follow-up (intervention: −26.63 minutes/day, 95% CI −32.05 to −21.20, P <.001; control: −18.43 minutes/day, 9

paliurus , although the weighted averages of pterocaryoside A, pterocaryoside B, and cyclocaric acid B per individual showed a decreasing trend with increasing the HDRs ( Figure 4 B), the quadratic equations could best describe the relationship between pterocaryosides (including A and B) and HDR ( p < 0.001), indicating that moderate herbivore damage would favor foliar pterocaryoside accumulations per individual in the field. 2.5.

Both in males and females significantly increasing trend in BMI, WC, WHR, systolic BP, cholesterol, LDL cholesterol, triglycerides and a decreasing trend in HDL cholesterol levels is observed (regression analyses, p < 0.001).

This was driven by an increasing number of firearm injuries per 10 000 ED visits at the S site (β=+0.11 (SE 0.02), p≤0.001), whereas the W site had no change over time and the MA and NE sites both had a decreasing trend over time (β=−0.19 (SE 0.04), p=0.001; β=−0.0.15 (SE 0.04), p=0.002, respectively).

The overall median completion rate was 60.1% (IQR, 37.9%-81.0%); this rate was slightly lower during home care vs inpatient stay (57.5% [IQR, 30.7%-85.9%] vs 65.0% [IQR, 49.6%-92.5%], respectively; P = .01), with a decreasing trend over time (65.6% [IQR, 51.6%-85.9%] for the first 90 days vs 42.9% [IQR, 29.3%-82.3%] for beyond 90 days; P < .001).

However, HDL-C displayed a decreasing trend from quartile 1 to quartile 4 ( P < 0.001; Table 2 ).

ACTH : it showed a decreasing trend during the profile in both conditions ( p = 0.001 placebo, p = 0.012 diclofenac) but at a direct comparison, the two trends did not show any significant difference (Table 1 and Supplementary Fig. 2 a-b).

coli to third-generation cephalosporins showed a decreasing trend (ceftazidime, 6% to 2%; ceftriaxone, 8% to 7%; both P ≤ 0.001).

The total detection rate of newly diagnosed patients with echinococcosis, as well as that of CE and AE, demonstrated a decreasing trend year by year ( χ 2 = 1,054.785, 925.936, 196.018; P < 0.001).

Results The serum levels of 25(OH)D, 25(OH)D3, and F25(OH)D showed a decreasing trend ( z = −2.781–−3.996, P < 0.01) in RA patients with CKD progression from mild to severe, while C3-epi-25(OH)D3 showed an increasing trend ( z = 6.741, P < 0.001) and 25(OH)D2 showed no significant difference among the groups ( z = 0.976, P = 0.329).

Compared with BJT, the JST outpatient services had an increasing trend in inflation-adjusted per-visit healthcare charges (APC = 3.4%, P <0.001) and no DIT in inflation-adjusted per-visit medicine charges or physician workload ( P = 0.40 and P = 0.134, respectively), while the JST inpatient service had a decreasing trend in inflation-adjusted per-visit medicine-charges (APC = -5.2%, P = 0.015) and no DIT in inflation-adjusted per-visit healthcare charges or physician workload ( P = 0.831 and P = 0.295, respectively).

1 A,B; the APC for each subgroup is presented in Table S2 ), except a decreasing trend of incidence in unknown receptor subtype subgroup (32.55 to 12.61 per 100,000 women from 2010 to 2019; APC: − 8.6, 95% CI − 11.1 to − 6.1, P < 0.001).

Likewise, we observed a decreasing trend in both sexes (male and female, APC = −7.6% and −5.1%, respectively; p -value < 0.001).

The values of all HRV indices showed a decreasing trend with age in healthy Korean adults, as observed in the Western population ( P < 0.001 for all indices); HF ( Y = −0.039x + 6.833, R 2 = 0.287), LF ( Y = −0.047x + 7.197, R 2 = 0.414), VLF ( Y = −0.025x + 6.861, R 2 = 0.177), TP ( Y = −0.034x + 8.082, R 2 = 0.352), HRV-index ( Y = −0.125x + 15.628, R 2 = 0.298), SDNN ( Y = −0.502x + 53.907, R 2 = 0.343), and pNN50 ( Y = −0.650x + 53.852, R 2 = 0.345) all decreased with age.

Interestingly, the prevalence of HTN and AS increased with age, while the prevalence of OB and MAFLD showed a decreasing trend with age ( P <0.001 for all trends) ( Figure S1F ).

Trend by age groups Throughout the entire study period, all age groups showed a decreasing trend in AAIR, in which the steepest decline belonged to the oldest age group, 85 + years (AAPC − 7.7, 95% CI: − 8.5 to − 7.1, p < 0.001), while the lowest rates were calculated for the 40- to 44-year age group (AAPC–− 1.8, 95% CI: − 4.3 to − 0.8, p = 0.188) (Fig. 1 ).

The SE slopes for low, moderate, and high astigmatism groups were −0.567D/y, −0.529 D/y, and −0.442 D/y, respectively, showing a decreasing trend with increasing astigmatism magnitude ( p < 0.001).

There was a decreasing trend in hospital mortality from 44% in 2005 to 24% in 2014 among hospital admissions for HRS in the United States (OR: 0.92, 95%CI: 0.90-0.94 per year; P < 0.001) (Figure 1A ).

Among HBM-related constructs, there was a decreasing trend for the prevalence of barriers, from its highest peak in July 2015 (56.2%) to the lowest prevalence in October 2018 (28.4%; difference, 27.8%; P < .001).

Additionally, counts of trapped hornets peaked in early-August, and exhibited a decreasing trend thereafter (GLMM, effect of date: F 1,19 = 495.081, P < 0.001; Fig. 2b ).

Among the different BALAD-2 scores, we found that the 5-year survival rate showed a decreasing trend with each increase from ≤2 to 4 (68.1%, 60.8% and 34.5%; Log-rank P <0.001; Figure 1 B).

From 2007 to 2013, there was an increasing trend in the use of norepinephrine (VUI norepinephrine was 0.24 in 2007 and 0.46 in 2013; p < 0.001) and a decreasing trend in the use of phenylephrine (VUI phenylephrine was 0.20 in 2007 and 0.08 in 2013; p < 0.001).

Results The urine cotinine concentration tended to decrease every year (2.91 ng/ml in 2009, 2.12 ng/ml in 2010, and 1.31 ng/ml in 2011), showing a decreasing trend ( P < 0.001).

As a result, a decreasing trend of HVPG was observed with a more distal catheter position in the hepatic vein during pressure measurement ( p < 0.001) (Fig. 3 e).